Article Text

CORD BLOOD PEPTIDE YY3-36 CONCENTRATIONS IN HUMAN FULL-TERM PREGNANCIES WITH NORMAL AND RESTRICTED FETAL GROWTH
  1. S Liosi1,
  2. D D Briana1,
  3. D Gourgiotis2,
  4. M Boutsikou1,
  5. S Baka1,
  6. VM Vraila2,
  7. D Hassiakos1,
  8. A Malamitsi-Puchner1
  1. 1Neonatal Division, 2nd Department of Obstetrics and Gynecology, Athens University Medical School, Athens, Greece
  2. 2Research Laboratories, 2nd Department of Pediatrics, Athens University Medical School, Athens, Greece

Abstract

Objective The gut hormone peptide YY3-36 (PYY3-36), present in placental and fetal intestinal tissues, inhibits gastric and pancreatic secretion, reduces intestinal motility and mesenteric blood flow and is involved in the regulation of food intake and energy balance. We aimed to study cord blood PYY3-36 concentrations in intrauterine growth-restricted (IUGR; usually associated with decreased intestinal growth, feeding intolerance and increased incidence of necrotising enterocolitis) and appropriate-for-gestational age (AGA) pregnancies and investigate possible correlations of PYY3-36 concentrations with several demographic parameters of infants at birth.

Methods PYY3-36 concentrations were determined by radioimmunoassay in 50 mixed arteriovenous cord blood samples from IUGR (n  =  14) and AGA (n  =  36) singleton full-term infants.

Results No significant differences in PYY3-36 concentrations were found between groups. In both groups, PYY3-36 concentrations decreased for every gram increase in birthweight (b  =  −0.077, 95% CI −0.134 to −0.02, p = 0.009). PYY3-36 concentrations were significantly lower in females (b  =  45.38, 95% CI −88.89 to −1.86, p = 0.041). Finally, PYY3-36 concentrations did not depend on parity or delivery mode.

Conclusions Lack of difference in PYY3-36 concentrations between IUGR and AGA groups possibly suggests that PYY3-36 may not be directly involved in the disturbances of intestinal growth and function associated with IUGR. However, the documented negative association with birth weight may imply the effect of this peptide on adiposity and energy homeostasis. Lower PYY3-36 concentrations in females may be due to stimulation of PYY3-36 receptors by oestradiol. However, as this is a pilot study, further reports are required to elucidate the role of PYY3-36 in the perinatal period.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.